282 related articles for article (PubMed ID: 27604683)
1. Antiproliferative and Apoptotic Effect of Dendrosomal Curcumin Nanoformulation in P53 Mutant and Wide-Type Cancer Cell Lines.
Montazeri M; Pilehvar-Soltanahmadi Y; Mohaghegh M; Panahi A; Khodi S; Zarghami N; Sadeghizadeh M
Anticancer Agents Med Chem; 2017; 17(5):662-673. PubMed ID: 27604683
[TBL] [Abstract][Full Text] [Related]
2. Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines.
Montazeri M; Sadeghizadeh M; Pilehvar-Soltanahmadi Y; Zarghami F; Khodi S; Mohaghegh M; Sadeghzadeh H; Zarghami N
Int J Pharm; 2016 Jul; 509(1-2):244-254. PubMed ID: 27234697
[TBL] [Abstract][Full Text] [Related]
3. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M
Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
Ebrahimi M; Babaei E; Neri F; Feizi MAH
Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
[TBL] [Abstract][Full Text] [Related]
5. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.
Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW
Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336
[TBL] [Abstract][Full Text] [Related]
6. Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment.
Shiri S; Alizadeh AM; Baradaran B; Farhanghi B; Shanehbandi D; Khodayari S; Khodayari H; Tavassoli A
Asian Pac J Cancer Prev; 2015; 16(9):3917-22. PubMed ID: 25987060
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells.
Esmatabadi MJD; Motamedrad M; Sadeghizadeh M
Phytomedicine; 2018 Mar; 42():56-65. PubMed ID: 29655698
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
11. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.
Liontas A; Yeger H
Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054
[TBL] [Abstract][Full Text] [Related]
12. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced surge of macrophage foam cell formation, oxidative damage, and cytokine release is attenuated by a nanoformulation of curcumin.
Soltani B; Bodaghabadi N; Ghaemi N; Sadeghizadeh M
Int J Radiat Biol; 2017 Mar; 93(3):303-314. PubMed ID: 27807992
[TBL] [Abstract][Full Text] [Related]
14. Curcumin nanocapsules effect in apoptotic processes, gene expression, and cell cycle on Hep-G2 cell lines.
Moawad M; Nasr GM; Osman AS; Shaker ES
Int J Immunopathol Pharmacol; 2023; 37():3946320231176396. PubMed ID: 37190979
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing effect of dendrosomal nanoformulation of curcumin on cancer cells.
Varnamkhasti TJ; Jafarzadeh M; Sadeghizadeh M; Aghili M
Pharmacol Rep; 2022 Aug; 74(4):718-735. PubMed ID: 35819593
[TBL] [Abstract][Full Text] [Related]
16. The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma.
Su CC; Wang MJ; Chiu TL
Int J Mol Med; 2010 Aug; 26(2):217-24. PubMed ID: 20596601
[TBL] [Abstract][Full Text] [Related]
17. Dendrosomal curcumin inhibits metastatic potential of human SW480 colon cancer cells through Down-regulation of Claudin1, Zeb1 and Hef1-1 gene expression.
Dehghan Esmatabadi MJ; Farhangi B; Safari Z; Kazerooni H; Shirzad H; Zolghadr F; Sadeghizadeh M
Asian Pac J Cancer Prev; 2015; 16(6):2473-81. PubMed ID: 25824783
[TBL] [Abstract][Full Text] [Related]
18. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells.
Chiu TL; Su CC
Int J Mol Med; 2009 Apr; 23(4):469-75. PubMed ID: 19288022
[TBL] [Abstract][Full Text] [Related]
20. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells.
Tahmasebi Mirgani M; Isacchi B; Sadeghizadeh M; Marra F; Bilia AR; Mowla SJ; Najafi F; Babaei E
Int J Nanomedicine; 2014; 9():403-17. PubMed ID: 24531649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
